StonvexLoading…
StonvexStonvexStonvexCore line items from FUSE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $1.88M | $7.71M | $1.95M | $8.81M |
Operating Income | $-3.04M | $-5.95M | $-1.32M | $-8.19M |
Net Income | $-872.00K | $-928.00K | $-2.06M | $-15.38M |
EPS (Diluted) | $-0.03 | $-0.08 | $-0.03 | $-2.21 |
Total Assets | $4.94M | $7.54M | Not available | $5.55M |
Total Liabilities | $19.98M | $22.11M | Not available | $29.85M |
Cash & Equivalents | $1.77M | $4.22M | Not available | $500.00K |
Free Cash Flow OCF − CapEx | $-2.24M | $-5.58M | $-230.00K | $-2.22M |
Shares Outstanding | 28.94M | 28.94M | 7.27M | 7.26M |